Biomedal

Biomedal is a privately-held, revenue-generating biotechnology company that has established a niche in the life science research tools market. Operating for over two decades, it has developed specialized diagnostic services and products, with a particular historical focus on metabolic disorders such as celiac disease through its gluten detection technology. The company's business model appears to be a hybrid of service provision and product sales, catering to the research community rather than direct therapeutic development.

Immunoassay development platform utilizing monoclonal antibodies for the detection of specific proteins and peptides, notably gluten/gliadin for celiac disease management, adaptable for custom assay services.

Biomedal competes in a fragmented market against giants like Thermo Fisher Scientific, Merck, and Abcam in the broad research tools space, and against specialized diagnostic companies like Immunogenics in the celiac detection niche. Its differentiation lies in its deep, specialized expertise in immunochemistry for complex samples and a flexible service model.